AstraZeneca antibody therapy prevents COVID-19 in trial, company says

AstraZeneca released Phase 3 data showing promising results for a combination antibody therapy that prevents infectious-disease, possibly opening the door to an alternative option for people who may not see the full protective benefits from the currently authorized infectious-disease. The PROVENT pre-exposure prophylaxis trial showed AZD7442 reduced the risk of developing symptomatic COVID-19 by up…

Read More

Data behind US COVID-19 booster plan shows waning vaccine effectiveness

The data behind health officials’ plan to offeinfectious-disease infectious-disease booster shots to fully vaccinated Americans showed waning effectiveness against infection for both authorized mRNA jabs. The studies, published by the Centers for Disease Control and Prevention (CDC) on Wednesday and discussed during a White House COVID-19 response briefing, involved data collected in New York, U.S….

Read More

WHO: Warns against COVID-19 boosters before 1st vaccines

The chief scientist of the world-health-organization” target=”_blank”>World Health Organization< pandemic if high-income countries start administering vaccine boosters ahead of poorer countries without vaccines. With the U.S. health officials recommending booster shots for all Americans who have already been vaccinated, Dr. Soumya Swaminathan expressed concern that leaving billions of people in the developing world unvaccinated could…

Read More

COVID-19 vaccine boosters: Here's what to know

U.S. health officials may soon recommend infectious-disease booster shots for fully vaccinated Americans. A look at what we know about boosters and how they could help fight the coronavirus: WHY MIGHT WE NEED BOOSTERS? It’s common for protection from vaccines to decrease over time. A tetanus booster, for example, is recommended every 10 years. Researchers…

Read More